CD40LG and neoplasm: Infection of tumor cells with oncolytic vectors will trigger tumor cell death, thereby boosting tumor antigen release in the tumor micromilieu, while the CD40L transgene is designed to ensure optimal DC/T-cell interaction [152, 153].